Current Ratio
1.56x
Period-end balance · Through 30 Sep 2026
Iris Acquisition Corp II financial metrics
Period Q3 2026 · Filed 06 Nov 2026
Key metrics snapshot
Financial Health
| Metric | Latest value | YoY relative change |
|---|---|---|
| Current Ratio |
1.56x
Period-end balance · 30 Sep 2026
|
Growth
| Metric | Latest value | YoY relative change |
|---|---|---|
| Net Income (Loss) Attributable to Parent |
$1,430,836
Reported period · 30 Sep 2026
|
Supporting Metrics
These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.
| Metric | Latest value | YoY relative change |
|---|---|---|
| Additional Paid in Capital |
$0
Period-end balance · 30 Sep 2026
|
|
| Assets |
$173,223,755
Period-end balance · 30 Sep 2026
|
|
| Assets, Current |
$650,331
Period-end balance · 30 Sep 2026
|
|
| Cash and Cash Equivalents, at Carrying Value |
$574,063
Period-end balance · 30 Sep 2026
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$574,063
Period-end balance · 30 Sep 2026
|
|
| General and Administrative Expense |
$175,559
Reported period · 30 Sep 2026
|
+248% |
| Liabilities |
$7,531,476
Period-end balance · 30 Sep 2026
|
|
| Liabilities and Equity |
$173,223,755
Period-end balance · 30 Sep 2026
|
|
| Liabilities, Current |
$416,476
Period-end balance · 30 Sep 2026
|
|
| Nonoperating Income (Expense) |
$1,606,395
Reported period · 30 Sep 2026
|
|
| Operating Income (Loss) |
-$175,559
Reported period · 30 Sep 2026
|
-248% |
| Preferred Stock, Par or Stated Value Per Share |
0.0001
Period-end balance · 30 Sep 2026
|
|
| Preferred Stock, Shares Authorized |
1,000,000
Period-end balance · 30 Sep 2026
|
|
| Preferred Stock, Shares Issued |
0
Period-end balance · 30 Sep 2026
|
|
| Preferred Stock, Shares Outstanding |
0
Period-end balance · 30 Sep 2026
|
|
| Retained Earnings (Accumulated Deficit) |
-$6,858,783
Period-end balance · 30 Sep 2026
|
|
| Stockholders' Equity Attributable to Parent |
-$6,858,177
Period-end balance · 30 Sep 2026
|
-26876% |
Comparisons, sources and research notes
Sources and sharing
IRAB - Iris Acquisition Corp II Financial Facts
- Context
- Latest metrics period: Q3 2026
- Latest reported value
- Current Ratio 1.56x
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.
Tracking and update notes
Why revisit this company facts page
Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.
- Latest source-backed update
- Latest metrics period Q3 2026
- Why come back
- Use the next filing cycle to compare new facts against this baseline and then verify the detailed metric history.
- Current latest metrics period: Q3 2026.
- Most recent SEC facts end date on this page: 30 Sep 2026.
- Save this filer to return when the next filing-backed metric period changes the picture.
Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.
Latest update
Latest update for IRAB - Iris Acquisition Corp II
Latest financial period: Q3 2026. Reopen this facts page to verify the newest reported period against the prior baseline.
Update date
06 Nov 2026
Page type
Company facts
Latest period
Q3 2026
SEC-backed company facts were refreshed from filings filed on 06 Nov 2026.
Benchmark Context
How Current Ratio compares
Current Ratio does not yet have enough prior-period data for a historical comparison on this page.
Compared with
Compared with Iris Acquisition Corp II's recent history first. Same-industry peer context appears only when enough SEC-backed benchmark coverage exists.
Why this is notable
Current Ratio already has a self-history signal here, but same-industry benchmark context waits until the benchmark sample is strong enough.
- Latest comparable period on this page: Q3 2026.
- Peer context will appear when enough companies report a comparable value for this metric.
- Open the metric history first if you want to verify the exact period-to-period change.
Industry benchmark context uses SEC-reported values from the same methodology version. Latest periods may differ across companies.
Filing notes and source
Key facts
- IRAB - Iris Acquisition Corp II financial facts use SEC filings; any third-party reference is labeled separately.
- Latest metrics period on this page: Q3 2026.
- Headline metric: Current Ratio 1.56x.
Change
- Comparable YoY change is unavailable for this metric.
- Most recent SEC facts end date: 30 Sep 2026.
Research use
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Metric cards link to SEC history; a third-party reference may use a different or unverified reporting period.
Evidence
Based on latest 10-Q/10-K
View source filing
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.
Latest financial snapshot (2026-09-30) highlights Current Ratio 1.56x.
Valuation Snapshot
SEC-only DCF estimate using a normalized free cash flow base, cash, debt, and reported share count when available.
No market comparison
USD inputs only. Cash and complete debt must share the latest balance date. Missing balances are unknown, never zero; equity value and market EV remain unavailable until both are verified.
DCF estimate is unavailable because required valuation inputs are missing.
Missing: Free cash flow and Shares.
Input periods, units and SEC sources
Equity value = DCF enterprise value + cash − debt. Cash flow uses matching annual or trailing-12-month periods.
- Operating cash flow: unavailable on a verified comparable basis
- Capital expenditures: unavailable on a verified comparable basis
- Cash and equivalents: 574,063.0 USD · through 2026-09-30 SEC source
- Debt: unavailable on a verified comparable basis
Data confidence notes
- Free cash flow unavailable: matching usd annual or trailing-12-month operating cash flow and cash capex are required
- Debt unavailable: no complete usd debt balance at the latest balance date
- Valuation unavailable: free cash flow is missing
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
100.0/100
Strong Confidence low
Financial Health
- Current Ratio
- 1.56x
Strengths
Current Ratio
Watchpoints
No major risk flags from available metrics.
Calculation methodology and other links
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- Operating Income / Revenues using matching TTM or quarter periods; basis shown per metric
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- Revenues YoY using available TTM or quarter comparison; basis shown per metric
- Net Income YoY using available TTM or quarter comparison; basis shown per metric
CIK / security context first